Additive effect of prostaglandin E2 and adenosine in mouse experimental autoimmune encephalomyelitis

Prostaglandins and Other Lipid Mediators

Volumn 100-101, Issue 1, 2013, Pages 30-35

  Xu, Jingjing ^a,c   Guo, Si ^b   Jia, Zhankui ^c   Ma, Shengli ^c   Li, Zhentao ^c   Xue, Rui ^c  

^a FUDAN UNIVERSITY   (China)

^b HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Adenosine; EAE; Immunomodulation; Multiple sclerosis; PGE2

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 17; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG EFFECT; FEMALE; MOUSE; NONHUMAN;

ADENOSINE; ANALYSIS OF VARIANCE; ANIMALS; DINOPROSTONE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; RECEPTOR, ADENOSINE A2A; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; T-LYMPHOCYTES; TIME FACTORS;

EID: 84874968786     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2012.11.004     Document Type: Article

References (32)

1. H.F. McFarland, and R. Martin Multiple sclerosis: a complicated picture of autoimmunity Nat Immunol 8 2007 913 919
2. H.L. Weiner The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann Neurol 65 2009 239 248
3. L. Steinman A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage Nat Med 13 2007 139 145
4. L. Steinman A rush to judgment on Th17 J Exp Med 205 2008 1517 1522
5. L. Steinman, and S.S. Zamvil How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis Ann Neurol 60 2006 12 21
6. T. Korn, E. Bettelli, M. Oukka, and V.K. Kuchroo IL-17 and Th17 cells Annu Rev Immunol 27 2009 485 517
7. S.G. Harris, J. Padilla, L. Koumas, D. Ray, and R.P. Phipps Prostaglandins as modulators of immunity Trends Immunol 23 2002 144 150
8. J.S. Goodwin, and J. Ceuppens Regulation of the immune response by prostaglandins J Clin Immunol 3 1983 295 315
9. + absorption by activating the EP1 receptor J Clin Invest 102 1998 194 201
10. E.J. Goetzl, S. An, and W.L. Smith Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases FASEB J 9 1995 1051 1058
11. T. Khayrullina, J.H. Yen, H. Jing, and D. Ganea In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells J Immunol 181 2008 721 735
12. Y. Esaki, Y. Li, and D. Sakata Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis Proc Natl Acad Sci U S A 107 2010 12233 12238
13. K. Boniface, K.S. Bak-Jensen, and Y. Li Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling J Exp Med 206 2009 535 548
14. G. Burnstock The past, present and future of purine nucleotides as signalling molecules Neuropharmacology 36 1997 1127 1139
15. G. Hasko, and B.N. Cronstein Adenosine: an endogenous regulator of innate immunity Trends Immunol 25 2004 33 39
16. M.V. Sitkovsky, and A. Ohta The 'danger' sensors that stop the immune response: the A2 adenosine receptors? Trends Immunol 26 2005 299 304
17. G. Haskó, D.G. Kuhel, and J.F. Chen Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms FASEB J 14 2000 2065 2074
18. G. Haskó, C. Szabó, Z.H. Németh, V. Kvetan, S.M. Pastores, and E.S. Vizi Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice J Immunol 157 1996 4634 4640
19. J.M. Wilson, W.G. Ross, and O.N. Agbai The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells J Immunol 182 2009 4616 4623
20. J.A. Fotheringham, M.B. Mayne, J.A. Grant, and J.D. Geiger Activation of adenosine receptors inhibits tumor necrosis factor-alpha release by decreasing TNF-alpha mRNA stability and p38 activity Eur J Pharmacol 497 2004 87 95
21. C.P. Sevigny, L. Li, and A.S. Awad Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition J Immunol 178 2007 4240 4249
22. R. Polosa, and S.T. Holgate Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammation Curr Drug Targets 7 2006 699 706
23. G. Bamias, and F. Cominelli Immunopathogenesis of inflammatory bowel disease: current concepts Curr Opin Gastroenterol 23 2007 365 369
24. A. Hansel, C. Gunther, and J. Ingwersen Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses J Allergy Clin Immunol 127 2011 787 794
25. Y. Su, X. Huang, and T. Raskovalova Cooperation of adenosine and prostaglandin E2 (PGE2) in amplification of cAMP-PKA signaling and immunosuppression Cancer Immunol Immunother 57 2008 1611 1623
26. A. Kosmaczewska, J. Swierkot, L. Ciszak, and P. Wiland The role of Th1 Th17, and Treg cells in the pathogenesis of rheumatoid arthritis including anti-inflammatory action of Th1 cytokines Postepy Hig Med Dosw (Online) 65 2011 397 403
27. B. Clapp, J.A. Skyberg, X. Yang, T. Thornburg, N. Walters, and D.W. Pascual Protective live oral brucellosis vaccines stimulate Th1 and Th17 cell responses Infect Immun 79 2011 4165 4174
28. T. Miyabayashi, H. Kagamu, and J. Koshio Vaccination with CD133(+) melanoma induces specific Th17 and Th1 cell-mediated antitumor reactivity against parental tumor Cancer Immunol Immunother 60 2011 1597 1608
29. H. Fujino, S. Salvi, and J.W. Regan Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2 Mol Pharmacol 68 2005 251 259
30. A.N. Hata, and R.M. Breyer Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation Pharmacol Ther 103 2004 147 166
31. M.V. Sitkovsky, D. Lukashev, and S. Apasov Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors Annu Rev Immunol 22 2004 657 682
32. T. Grader-Beck, A.A. van Puijenbroek, L.M. Nadler, and V.A. Boussiotis cAMP inhibits both Ras and Rap1 activation in primary human T lymphocytes, but only Ras inhibition correlates with blockade of cell cycle progression Blood 101 2003 998 1006